Clinical endpoints of needle-free jet injector treatment: An in depth understanding of immediate skin responses.

dermatology drug delivery injection intralesional jet injection needle-free injection pneumatic injection

Journal

Lasers in surgery and medicine
ISSN: 1096-9101
Titre abrégé: Lasers Surg Med
Pays: United States
ID NLM: 8007168

Informations de publication

Date de publication:
07 2022
Historique:
revised: 27 12 2021
received: 12 08 2021
accepted: 10 01 2022
pubmed: 25 1 2022
medline: 14 6 2022
entrez: 24 1 2022
Statut: ppublish

Résumé

Needle-free jet injectors have been used in dermatological practice for many years. However, predefined clinical endpoints that guide physicians to choose optimal device settings have not been clearly defined. Here, we evaluate immediate skin responses as clinical endpoints for needle-free jet injector treatments. We injected methylene blue in ex vivo human skin using an electronically-controllable pneumatic injector (EPI; 3-6 bar, 50-130 µl; n = 63), and a spring-loaded jet injector (SLI) with fixed settings (100 µl; n = 9). We measured the immediate skin papule (3D-camera), residual surface fluid (pipette), dermal dye distribution by estimating depth and width, and subcutaneous dye deposition. EPI with 4 bar and 100 µl resulted in the largest skin papule of 48.7 mm The immediate skin papule and residual surface fluid correspond with dermal drug deposition and are relevant clinical endpoints for needle-free jet injector treatments in dermatological practice.

Identifiants

pubmed: 35067934
doi: 10.1002/lsm.23521
pmc: PMC9303610
doi:

Substances chimiques

Methylene Blue T42P99266K

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

693-701

Informations de copyright

© 2022 The Authors. Lasers in Surgery and Medicine published by Wiley Periodicals LLC.

Références

J Dermatolog Treat. 2006;17(2):112-6
pubmed: 16766336
Expert Opin Drug Deliv. 2021 May;18(5):635-641
pubmed: 33317342
J Control Release. 2019 Jul 28;306:83-88
pubmed: 31150748
J Skin Cancer. 2011;2011:790509
pubmed: 21188233
Lasers Surg Med. 2022 Jul;54(5):693-701
pubmed: 35067934
Lasers Surg Med. 2021 Jan;53(1):141-147
pubmed: 32515075
J Cosmet Laser Ther. 2019;21(6):346-348
pubmed: 31547789
Br J Dermatol. 2014 May;170(5):1191-2
pubmed: 24329152
Pharm Res. 2007 Aug;24(8):1501-7
pubmed: 17380263
J Am Acad Dermatol. 2016 May;74(5):821-33; quiz 834, 833
pubmed: 27085228
Lasers Surg Med. 2020 Jan;52(1):33-37
pubmed: 31788834
Lancet. 2014 Aug 23;384(9944):674-81
pubmed: 24881803
Drug Deliv. 2019 Dec;26(1):384-392
pubmed: 30905213
Science. 1963 Feb 22;139(3556):766-7
pubmed: 17829126
Nat Rev Drug Discov. 2006 Jul;5(7):543-8
pubmed: 16816837
Dermatol Surg. 2017 Feb;43(2):264-269
pubmed: 27893541
J Control Release. 2019 Aug 10;307:200-210
pubmed: 31252035
Clin Cosmet Investig Dermatol. 2018 May 01;11:231-238
pubmed: 29750049
J Cosmet Dermatol. 2020 Aug;19(8):1966-1972
pubmed: 32603031

Auteurs

Liora Bik (L)

Department of Dermatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.

Martijn B A van Doorn (MBA)

Department of Dermatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.

Neill Boeijink (N)

Department of Dermatology, Amsterdam UMC Medical Center, Amsterdam, The Netherlands.

Medelyn Wennekers (M)

Department of Dermatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.

Arne A Meesters (AA)

Department of Dermatology, Amsterdam UMC Medical Center, Amsterdam, The Netherlands.

Peter Bloemen (P)

Department of Biomedical Engineering, Amsterdam UMC Medical Center, Amsterdam, The Netherlands.

Merete Haedersdal (M)

Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.

Albert Wolkerstorfer (A)

Department of Dermatology, Amsterdam UMC Medical Center, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH